{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:24:58Z","timestamp":1791019498401,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T00:00:00Z","timestamp":1322784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0028350","type":"journal-article","created":{"date-parts":[[2011,12,3]],"date-time":"2011-12-03T19:20:04Z","timestamp":1322940004000},"page":"e28350","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Constitutive MAP Kinase Activation in Hematopoietic Stem Cells Induces a Myeloproliferative Disorder"],"prefix":"10.1371","volume":"6","author":[{"given":"Eva","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonari","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev.immunol.21.120601.141007","article-title":"BIOLOGY OF HEMATOPOIETIC STEM CELLS AND PROGENITORS: Implications for Clinical Application.","volume":"21","author":"M Kondo","year":"2003","journal-title":"Annu Rev of Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/annonc\/mdl443","article-title":"Epidemiology of hematological malignancies.","volume":"18","author":"D Rodriguez-Abreu","year":"2007","journal-title":"Ann Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbi.2009.10.009","article-title":"The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms.","volume":"184","author":"JW Vardiman","year":"2010","journal-title":"Chem Biol Interact"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"JW Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"627(611)","DOI":"10.1038\/nrclinonc.2009.149","article-title":"Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.(Clinical report).","volume":"6","author":"A Tefferi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms.","volume":"100","author":"JW Vardiman","year":"2002","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.","volume":"114","author":"JW Vardiman","year":"2009","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/leu.2008.162","article-title":"Juvenile myelomonocytic leukemia and chronic myelomonocytic leukemia.","volume":"22","author":"PD Emanuel","year":"2008","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","article-title":"Map kinase signaling pathways and hematologic malignancies.","volume":"101","author":"LC Platanias","year":"2003","journal-title":"Blood"},{"key":"ref10","first-page":"4682","article-title":"RAS oncogenes in human cancer: a review.","volume":"49","author":"J Bos","year":"1989","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy.","volume":"3","author":"J Downward","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nrc2109","article-title":"Hyperactive Ras in developmental disorders and cancer.","volume":"7","author":"S Schubbert","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","article-title":"Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder.","volume":"103","author":"DT Le","year":"2004","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","article-title":"Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder.","volume":"101","author":"BS Braun","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI20476","article-title":"Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative disease.","volume":"113","author":"IT Chan","year":"2004","journal-title":"J Clin Invest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1182\/blood-2008-01-134262","article-title":"Oncogenic Kras-induced leukemogeneis: hematopoietic stem cells as the initial target and lineage-specific progenitors as the potential targets for final leukemic transformation.","volume":"113","author":"J Zhang","year":"2009","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000059","DOI":"10.1371\/journal.pbio.1000059","article-title":"Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells.","volume":"7","author":"AJ Sabnis","year":"2009","journal-title":"PLoS Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-Kinase Pathway in Cancer.","volume":"4","author":"N Chalhoub","year":"2009","journal-title":"Annu Rev Pathol: Mechanisms of Disease"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase-AKT pathway in human cancer.","volume":"2","author":"I Vivanco","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood-2009-06-229443","article-title":"Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.","volume":"115","author":"MG Kharas","year":"2010","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature06933","article-title":"Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.","volume":"453","author":"W Guo","year":"2008","journal-title":"Nature"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature04703","article-title":"Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells.","volume":"441","author":"\u00d6H Yilmaz","year":"2006","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature04747","article-title":"PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.","volume":"441","author":"J Zhang","year":"2006","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","article-title":"Differential regulation and properties of MAPKs.","volume":"26","author":"M Raman","year":"2007","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/\/Raf\/\/MEK\/\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.","volume":"17","author":"F Chang","year":"2000","journal-title":"Leukemia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.8052857","article-title":"Transformation of Mammalian Cells by Constitutely Active MAP Kinase Kinase.","volume":"265","author":"SJ Mansour","year":"1994","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.onc.1203337","article-title":"A conditionally-active form of MEK1 results in autocrine transformation of human and mouse hematopoietic cells.","volume":"19","author":"WL Blalock","year":"2000","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/35030112","article-title":"Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.","volume":"407","author":"M Kondo","year":"2000","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1084\/jem.20050967","article-title":"Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates.","volume":"202","author":"E Passegu\u00e9","year":"2005","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood-2006-01-013490","article-title":"Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo.","volume":"108","author":"BS Braun","year":"2006","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood-2004-04-1362","article-title":"Constitutive activation of the MEK\/ERK pathway mediates all effects of oncogenic H-ras expression in primary erythroid progenitors.","volume":"104","author":"J Zhang","year":"2004","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4161\/cc.6.5.3919","article-title":"Oncogenes in Myeloproliferative Disorders.","volume":"6","author":"A Tefferi","year":"2007","journal-title":"Cell Cycle"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccr.2004.12.004","article-title":"Focus on myeloproliferative diseases and myelodysplastic syndromes.","volume":"6","author":"RA Van Etten","year":"2004","journal-title":"Cancer Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/35102167","article-title":"Stem cells, cancer, and cancer stem cells.","volume":"414","author":"T Reya","year":"2001","journal-title":"Nature"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1182\/blood.V91.7.2272","article-title":"Systemic Overexpression of BCL-2 in the Hematopoietic System Protects Transgenic Mice From the Consequences of Lethal Irradiation.","volume":"91","author":"J Domen","year":"1998","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(94)90201-1","article-title":"DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.","volume":"79","author":"A Strasser","year":"1994","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia.","volume":"306","author":"AP Weng","year":"2004","journal-title":"Science"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1172\/JCI35090","article-title":"Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras\u2013initiated leukemia.","volume":"118","author":"MY Chiang","year":"2008","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6311","DOI":"10.1073\/pnas.0609608104","article-title":"Indentification of a bone marrow precursor of the earliest thymocytes in adult mouse.","volume":"104","author":"A Lai","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1074-7613(00)00009-1","article-title":"Notch1 Signaling Promotes the Maturation of CD4 and CD8 SP Thymocytes.","volume":"13","author":"ML Deftos","year":"2000","journal-title":"Immunity"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/sj.leu.2402109","article-title":"Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells.","volume":"15","author":"WL Blalock","year":"2001","journal-title":"Leukemia"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/sj.leu.2402945","article-title":"Signal transduction mediated by the Ras\/\/Raf\/\/MEK\/\/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.","volume":"17","author":"F Chang","year":"2003","journal-title":"Leukemia"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.8052857","article-title":"Transformation of mammalian cells by constitutively active MAP kinase kinase.","volume":"265","author":"SJ Mansour","year":"1994","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"76ra27","DOI":"10.1126\/scitranslmed.3001069","article-title":"A MEK Inhibitor Abrogates Myeloproliferative Disease in Kras Mutant Mice.","volume":"3","author":"N Lyubynska","year":"2011","journal-title":"Science Trans Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts.","volume":"13","author":"SR Datta","year":"1999","journal-title":"Genes Dev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.","volume":"348","author":"A Strasser","year":"1990","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.","volume":"335","author":"DL Vaux","year":"1988","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nri2304","article-title":"Molecular pathogenesis of T-cell leukaemia and lymphoma.","volume":"8","author":"I Aifantis","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1182\/blood-2005-02-0734","article-title":"c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.","volume":"106","author":"H Luo","year":"2005","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1073\/pnas.0510304103","article-title":"Antagonistic effect of CCAAT enhancer-binding protein-\u03b1 and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.","volume":"103","author":"C-L Hsu","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-02-071761","article-title":"Activation of mitogen-activated protein kinase kinase (MEK)\/extracellular signal regulated kinase (ERK) signaling pathway is involved in myeloid lineage commitment.","volume":"110","author":"C-L Hsu","year":"2007","journal-title":"Blood"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","article-title":"Enhancement of Hematopoietic Stem Cell Repopulating Capacity and Self-Renewal in the Absence of the Transcription Factor C\/EBP\u03b1.","volume":"21","author":"P Zhang","year":"2004","journal-title":"Immunity"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1097-2765(00)80308-1","article-title":"Ras Enhances Myc Protein Stability.","volume":"3","author":"R Sears","year":"1999","journal-title":"Mol Cell"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1101\/gad.836800","article-title":"Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.","volume":"14","author":"R Sears","year":"2000","journal-title":"Genes Dev"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1002\/j.1460-2075.1994.tb06724.x","article-title":"c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II.","volume":"13","author":"LH Li","year":"1994","journal-title":"EMBO J"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1432-1033.1995.397zz.x","article-title":"Myc Inhibits CCAAT\/Enhancer-Binding Protein \u03b1-Gene Expression in HIB-1B Hibernoma Cells Through Interactions with the Core Promoter Region.","volume":"232","author":"P Antonson","year":"1995","journal-title":"Eur J Biochem"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1128\/MCB.21.11.3789-3806.2001","article-title":"c-Myc Is a Critical Target for C\/EBP\u03b1 in Granulopoiesis.","volume":"21","author":"LM Johansen","year":"2001","journal-title":"Mol Cell Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0028350","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T05:34:00Z","timestamp":1593322440000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0028350"}},"subtitle":[],"editor":[{"given":"Dimas Tadeu","family":"Covas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,12,2]]},"references-count":57,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2011,12,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0028350","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,2]]}}}